Alaunos Therapeutics, Inc. · NASDAQ:TCRT
Weis Holger received 4,363 Alaunos Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 6, 2026 · Filed Aug 11, 2026
On Aug 6, 2026, Weis Holger (CEO) received 4,363 Alaunos Therapeutics, Inc. shares as an award at US$2.01 for US$8,770, leaving 25,483 shares. Filed Aug 11, 2026 (Form 4).
- Awarded
- 4,363 shares
- Price
- US$2.01
- Value
- US$8,770
- Holding after
- 25,483 shares
- Trading plan
- No
- Role
- CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Award | 4,363 | US$2.01 | 25,483 | Direct |
Source
Related
- Alaunos Therapeutics, Inc.
- Weis Holger
- Alaunos Therapeutics, Inc. shareholders
- Form 4 · Weis Holger · Oct 8, 2026
- Form 4 · Weis Holger · Jul 27, 2026
- Form 4 · Weis Holger · Jul 2, 2026
- Form 4 · Weis Holger · Jun 17, 2026
- Form 4 · Weis Holger · May 27, 2026
- Schedule 13D · Fairmount Funds Management LLC · Oct 15, 2026
- Schedule 13D/A · Postma Robert W · Oct 15, 2026
- Form 4 · Postma Robert W · Oct 8, 2026
- Form 4 · Vieser Jaime · Oct 8, 2026
- Form 4 · Jerman Michael Allen · Oct 8, 2026